The DNA damage response, immunity and cancer

Area of Science:

• Genomics
• Cellular Biology
• Immunology

Background:

• The genome faces constant threats from exogenous and endogenous DNA damaging agents.
• DNA damage can lead to cell death and cancer initiation.
• Eukaryotes possess a complex DNA damage response (DDR) pathway to maintain genomic integrity.

Purpose of the Study:

• To review the DNA damage response (DDR) pathway.
• To explore the link between DDR and the innate immune system.
• To discuss the role of DDR in tumor surveillance and its implications for cancer therapy.

Main Methods:

• Review of existing literature on DNA damage response pathways.
• Analysis of studies demonstrating DDR activation during early tumorigenesis.
• Examination of research linking DDR to immune system activation via NKG2D ligands.

Main Results:

• The DNA damage response (DDR) pathway involves sensor proteins, signaling cascades, and transcriptional regulation.
• DDR activation leads to cell cycle arrest, DNA repair, or apoptosis.
• DDR is activated early in tumorigenesis, acting as a potential barrier.
• DDR induces cell surface ligands that activate natural killer (NK) cells and T cells via NKG2D.

Conclusions:

• The DNA damage response (DDR) pathway is crucial for maintaining genomic stability.
• DDR activation early in tumorigenesis highlights its role in cancer prevention.
• DDR interfaces with the innate immune system, enhancing tumor surveillance.
• Understanding DDR's role in immunity may offer new avenues for cancer therapies and drug development.